Press Release | Intralinks Studyspace™

Intralinks Adds Wingspan to eTMF Integration

Date: 10/09/2014

Intralinks® Holdings, Inc., a leading, global SaaS provider of inter-enterprise content management and collaboration solutions, announced today that it has selected Wingspan Technologies, a leading technology provider for the pharmaceutical and life science industries, to develop an integration for its electronic trial master file (eTMF) solution.

Intralinks’ novel electronic investigator site file (eISF) solution provides an easy and secure way to file site-based documents. The focus is on reducing costly site monitoring visits while improving efficiencies, sponsor visibility and inspection-readiness. More than 60,000 investigators over 2,100 active clinical trials use the Intralinks Studyspace™ platform today to collect critical clinical documents.

Wingspan’s cloud-based eTMF solution ensures that the trial master file contains the correct and appropriate documentation in a manner suitable for managing the conduct of the trial and enabling evaluation by audit or inspection. It supports collaboration across CROs and sponsors, while providing key features to specify and monitor what documents are required for each trial, when they are needed, and whether they have been received and passed the requisite quality check.

The integration between both solutions allows joint customers to gain significant efficiencies by eliminating manual steps when compiling and reconciling the clinical trial documentation. Content that is part of the eISF can be easily and automatically transferred to the electronic trial master file. 

“Critical study documents typically originate from or need to be filed in the sponsor’s trial master file,” said Andrew Mitchell, director of strategy and product marketing for life sciences at Intralinks. “Wingspan’s eTMF is widely adopted and highly regarded, so we’re delighted to be working with them to improve the clinical trial process.”

“This integration provides our customers with a best of breed solution to managing clinical trial documentation,” said Troy Deck, principal and founder of Wingspan. “Working with technology leaders like Intralinks is crucial to the value proposition that our customer’s demand in driving down the cost of clinical trials and streamlining the process.”

Founded in 1996, Intralinks is a leading global technology provider of cloud-based collaboration solutions that are used by 3.1 million business professionals from more than 90,000 organizations worldwide. A pioneer in software-as-a-service (SaaS) computing, the Intralinks platform supports a wide variety of use cases, including virtual data rooms (VDRs), which are used to support the complex and highly regulated process of managing strategic financial transactions with Intralinks Dealspace®. More recently the company launched Intralinks VIA™, which provides enterprises with a secure way to share, manage and protect data inside and outside the firewall, letting users safely collaborate and maintain lifetime control of their critical business content.

About Wingspan Technology, Inc.

Wingspan Technology, Inc. is the leading provider of life sciences and eClinical software solutions, including Wingspan eTMF and DocWay, the SharePoint/Documentum integration product suite. Wingspan's talented and knowledgeable engineering and project management teams offer in-depth industry knowledge and experience to companies in life sciences, pharmaceutical, financial services, and other fields.

Forward Looking Statements

The forward-looking statements contained in this press release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.  Forward-looking statements are express or implied statements that are not based on historical information and include, among other things, statements concerning Intralinks’ plans, intentions, expectations, projections, hopes, beliefs, objectives, goals and strategies.  These statements are neither promises nor guarantees, but are subject to a variety of risks and uncertainties, many of which are beyond our control and could cause actual results to differ materially from those contemplated in these forward-looking statements. Accordingly, there can be no assurance that the results or commitments expressed, projected or implied by any forward-looking statements will be achieved, and readers are cautioned not to place undue reliance on any forward-looking statements. The forward-looking statements in this press release speak only as of the date hereof.  As such, Intralinks undertakes no obligation to update or revise the information contained in this press release, whether as a result of new information, future events or circumstances or otherwise. For a detailed list of the factors and risks that could affect Intralinks’ financial results, please refer to Intralinks public filings with the Securities and Exchange Commission from time to time, including its Annual Report on Form 10-K for the year-ended December 31, 2013 and subsequent quarterly reports.  Intralinks undertakes no obligation to update or revise the information contained in this press release, whether as a result of new information, future events or circumstances or otherwise.

Trademarks and Copyright 

“Intralinks” and Intralinks’ stylized logo are the registered trademarks of Intralinks, Inc. This press release may also refer to trade names and trademarks of other organizations without reference to their status as registered trademarks. © 2014 Intralinks, Inc. All rights reserved.